Member Info for Dosanddonts

DRM72- Agree with you where is the coordinated roll out but who is in charge of Canada distribution, is that not part of US? As for price let’s remember that in the US & Canada the actual price to obtain an ED product is way higher due to doctor consultation & sky high prices, so £50 is still a good price considering! & this is what needs to remembered with the US rollout,l. Prices will be far greater than the UK as they are with all medical products! Do the maths higher sales price means bigger profits happy days to come.

I don’t see the harm in updating the market with positive regular financial updates, if sales are good as we suspect. Not the way to attract investors by having a news blackout which is what seems to be happening No consistency!

Buster-exactly 3year shelf life, so if we were scaled to produce for 10 new country releases with 2month left, what has happened? As with any producer we must have scaled up to produce so my worry is costs! Scaled up to produce and not producing product. Something has happened but what?

“Over the next six months or so, our distributors will look to move into the next phase of its rollout and launch of Eroxon® with at least a further ten new country launches.“ The only solid guarantee the BOD made & looks like they are going to fail to deliver? WHY Distributor or manufacture? Seems strange as Eroxon has a very limited shelve life & therefore they can’t manufacture too far in advance. So either Sales in the current countries have been through the roof so they can’t manufacture enough to release new countries or they have F’d up or someone has! If issue was delays due to demand I would have expected an RNS to stipulate that! So what the hell is happening????? Yes I am impatient but would just like to be kept in the loop as an investor, is that too much to ask?

Another month & still only 1 Country, still awaiting the other 9? 4month have passed and 2month remaining? Extension of coopers contract on 1 country release when 10 were planned??????

Pad- yor last post on FUM was in July hope you didn’t buy at 55p & sell at 32p! Lucky your not too attached to that 23p loss 😂

Who the hell would sell at 32p when it’s been at 44p, fair enough sell at 44p but 32p? Hoping Roy brings some stability to the SP & soon!

We can all see the shorters coming out the woodwork, but who do they think they are trying to sway on here, most of us have been & seen it before! Let them convince themselves into selling but ain’t convincing me 😂. Hold tight LTH

Why do people think we will see a big spike on distribution news for US when we saw very little when the deal was signed! & they stated 2025 for distribution so probably not coming til mid year. The next big rise will be on financials IMO, the SP has just regained where it was before the no reason, no news drop! Financials will concrete the potential earnings for the US OTC. I suspect good financials will see the SP hit the predictions of around £1.20 min!

Interested RNS every company this guy has been parts of according to RNS has been bought out??

FUM could have killed off the bad reviews if they had released ongoing sales figures! So why didn’t they? By not doing this they have also assisted in the decline of the SP why?? We are now only 2month from the 9 country product releases they promised & 3month from full year financials. We will find out soon.

Correction-Not surprising!!!!!

I totally agree people generally review when they are unhappy with a product & we know it only works for about 60% of people so reviews are surprising. Maybe they should offer a discount on repeat purchase if a review is left positive or negative this would incentivise people to leave a positive review.

Financials, financials, financials is what matters here now. If it’s proven sales have continued to be high in the uk with 20% market share, then multiply that up for the US X10, x10 for ROTW! Happy days! Everything else is speculation until then & we will continue to see highs & lows!

DRM72- we don’t know if they need to be creative with packs, offering smaller quantities as nobody knows what the sales figures are like! Due to the complete silence from the company! We will see in the next 3month and end of year financials in march!

Issue is one product is not a business, and FUM have currently put on hold all other developments which is also effecting the SP. IMO. Instead of the BOD paying themselves half a £mill each, they should have recruited staff and continued with the R&D. I think a lot of investor will be looking for an exit strategy because if LB start shifting shares they are in trouble.

Well had a reply from FUM:

“As we are sure you have seen, we gave a full update on our commercialisation plans for MED3000 in our latest financial results in September. Launches remain in line with September’s announcement and we will continue to share further information as soon as we are able to do so.”

Meaning they are expected a further 9 country launches within 6month of Septembers RNS.

My thoughts are the BOD are like the current government during the pandemic, making it up as they go along with bad decisions along the way! The only positive is that LB are holding tight so must be getting updates we aren’t privy to. I expect news start of the new year after the BOD have got their low price share allocation for 2025’s remuneration package.

Good luck Monty888, I’m starting to feel the same as you with FUM. But still hoping the silence is the BOD sorting things out for the storm coming. Jan-March needs to be productive for the SP otherwise I’m off.too!

Possible slow movement of Haleon maybe the fact Pfizer own 33% of the shares? Would you be in a rush to kill off your own revenue?? Roadblock!